Clinical Edge Journal Scan

Clinical Edge Journal Scan

Higher BMI linked to risk for second primary cancer in breast cancer survivors

• Read More

Clinical Edge Journal Scan

Overtreatment does not benefit older patients with early ER+ breast cancer

• Read More

Clinical Edge Journal Scan

Metastatic breast cancer: Add-on alisertib shows survival benefit

• Read More

Clinical Edge Journal Scan

Breast cancer: Detrimental effects of adjuvant chemotherapy on QoL in older patients subside after 3 years

• Read More

Clinical Edge Journal Scan

Pembrolizumab plus eribulin shows activity in HR+, HER2-negative breast cancer

• Read More

Clinical Edge Journal Scan

Breast cancer: IOERT boost noninferior to EBRT in terms of local control

• Read More

Clinical Edge Journal Scan

TNBC: Sacituzumab govitecan extends survival

• Read More

Clinical Edge Journal Scan

Dr. Erin Roesch: A proportion of patients diagnosed with HER2-positive early-stage breast cancer remain at risk for recurrence.

Author:

Erin Roesch, MD

• Read More

Clinical Edge Journal Scan

HER2+ BC: Recurrence risk remains even after achieving pCR with neoadjuvant pertuzumab+trastuzumab

• Read More

Clinical Edge Journal Scan

Risk of 5-year local recurrence declines with event-free years in newly diagnosed breast cancer

• Read More